Summit Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Sell
21,442
-9,322
-30% -$746K 0.02% 680
2025
Q4
$2.93M Sell
30,764
-1,511
-5% -$148K 0.04% 391
2025
Q3
$3.15M Sell
32,275
-444
-1% -$46K 0.05% 362
2025
Q2
$3.51M Buy
32,719
+3,224
+11% +$326K 0.08% 210
2025
Q1
$2.98M Buy
29,495
+12
+0% +$1.21K 0.08% 207
2024
Q4
$2.63M Buy
29,483
+3,428
+13% +$302K 0.09% 179
2024
Q3
$2.18M Buy
26,055
+601
+2% +$47.4K 0.09% 172
2024
Q2
$1.96M Buy
25,454
+9,823
+63% +$719K 0.09% 158
2024
Q1
$1.07M Sell
15,631
-138
-0.9% -$8.87K 0.06% 178
2023
Q4
$912K Buy
15,769
+445
+3% +$23.8K 0.06% 179
2023
Q3
$809K Sell
15,324
-149
-1% -$7.81K 0.06% 184
2023
Q2
$837K Sell
15,473
-403
-3% -$21K 0.06% 172
2023
Q1
$794K Buy
15,876
+117
+0.7% +$5.51K 0.07% 136
2022
Q4
$729K Buy
15,759
+1,451
+10% +$62.8K 0.07% 142
2022
Q3
$554K Buy
14,308
+2,331
+19% +$93.5K 0.05% 159
2022
Q2
$446K Buy
11,977
+536
+5% +$21.8K 0.04% 162
2022
Q1
$507K Buy
11,441
+2,224
+24% +$96.4K 0.04% 174
2021
Q4
$392K Buy
9,217
+1,552
+20% +$65.2K 0.03% 188
2021
Q3
$333K Buy
+7,665
New +$339K 0.03% 178

Other funds holding BSX

Summit Financial's BSX Position: Q1 2026 in Review

Summit Financial reduced its Boston Scientific (BSX) stake by 30% in Q1 2026, selling an estimated $746K and leaving 21,442 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #680.

Summit Financial first reported a position in BSX in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.51M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Summit Financial held 21,442 shares of Boston Scientific worth $1.35M as of Q1 2026.
  • Summit Financial sold 9,322 Boston Scientific shares in Q1 2026, an estimated $746K.
  • Boston Scientific made up 0.02% of Summit Financial's portfolio in Q1 2026, its #680 holding.
  • Summit Financial first reported a position in Boston Scientific in Q3 2021 and has held it in 19 quarters since.
  • Summit Financial's Boston Scientific position peaked at $3.51M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.